Cargando…
Genomic deletion and promoter methylation status of Hypermethylated in Cancer 1 (HIC1) in mantle cell lymphoma
Mantle cell lymphomas (MCL), characterized by the t(11;14)(q13;q32), frequently carry secondary genetic alterations such as deletions in chromosome 17p involving the TP53 locus. Given that the association between TP53-deletions and concurrent mutations of the remaining allele is weak and based on ou...
Autores principales: | Stöcklein, Heike, Hutter, Grit, Kalla, Jörg, Hartmann, Elena, Zimmermann, Yvonne, Katzenberger, Tiemo, Adam, Patrick, Leich, Ellen, Höller, Sylvia, Müller-Hermelink, Hans Konrad, Rosenwald, Andreas, Ott, German, Dreyling, Martin |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2713485/ https://www.ncbi.nlm.nih.gov/pubmed/19669207 http://dx.doi.org/10.1007/s12308-008-0008-6 |
Ejemplares similares
-
A cytomorphological and immunohistochemical profile of aggressive B-cell lymphoma: high clinical impact of a cumulative immunohistochemical outcome predictor score
por: Höller, Sylvia, et al.
Publicado: (2009) -
Hypermethylation of the HIC1 promoter and aberrant expression of HIC1/SIRT1 contribute to the development of thyroid papillary carcinoma
por: Wu, Wenyi, et al.
Publicado: (2016) -
Inhibition of focal adhesion kinase overcomes resistance of mantle cell lymphoma to ibrutinib in the bone marrow microenvironment
por: Rudelius, Martina, et al.
Publicado: (2018) -
Expression of the hypermethylated in cancer gene (HIC-1) is associated with good outcome in human breast cancer
por: Nicoll, G, et al.
Publicado: (2001) -
Class II transactivator (CIITA) mediates transcriptional repression of pdk4 gene by interacting with hypermethylated in cancer 1 (HIC1)
por: Fang, Mingming, et al.
Publicado: (2015)